Driehaus Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-598,792
| Closed | -$3M | – | 579 |
|
|
2018
Q2 | $3M | Buy |
598,792
+10,032
| +2% | +$50.3K | 0.1% | 225 |
|
|
2018
Q1 | $3.02M | Buy |
588,760
+40,718
| +7% | +$209K | 0.11% | 214 |
|
|
2017
Q4 | $3.29M | Buy |
548,042
+16,475
| +3% | +$99K | 0.13% | 206 |
|
|
2017
Q3 | $2.95M | Buy |
531,567
+22,032
| +4% | +$122K | 0.12% | 209 |
|
|
2017
Q2 | $2.36M | Buy |
509,535
+77,137
| +18% | +$358K | 0.09% | 236 |
|
|
2017
Q1 | $2.14M | Sell |
432,398
-366,193
| -46% | -$1.81M | 0.07% | 257 |
|
|
2016
Q4 | $8.86M | Buy |
798,591
+8,475
| +1% | +$94.1K | 0.31% | 68 |
|
|
2016
Q3 | $7.32M | Buy |
790,116
+176,880
| +29% | +$1.64M | 0.25% | 87 |
|
|
2016
Q2 | $3.89M | Sell |
613,236
-4,871
| -0.8% | -$30.9K | 0.14% | 159 |
|
|
2016
Q1 | $4.03M | Sell |
618,107
-22,271
| -3% | -$145K | 0.13% | 157 |
|
|
2015
Q4 | $5.19M | Buy |
640,378
+91,654
| +17% | +$743K | 0.18% | 131 |
|
|
2015
Q3 | $4.02M | Buy |
548,724
+171,108
| +45% | +$1.25M | 0.15% | 164 |
|
|
2015
Q2 | $3.87M | Buy |
377,616
+56,874
| +18% | +$583K | 0.13% | 193 |
|
|
2015
Q1 | $2.97M | Buy |
320,742
+107,062
| +50% | +$990K | 0.1% | 251 |
|
|
2014
Q4 | $1.5M | Buy |
+213,680
| New | +$1.5M | 0.06% | 358 |
|